SIBO Breath Testing
Gary Stapleton, President & CEO, Aerodiagnostics
At least 80% of IBS patients also suffer from Small Intestinal Bacterial Overgrowth. How can clinicians make that connection? Advances in testing and treatment now allow us to accurately match SIBO clinical impressions with hydrogen, methane, and carbon dioxide breath test results.
Watch this webinar to learn about SIBO testing, clinical impressions, and unique breath test results. Special guest Gary Stapleton, CEO of Aerodiagnostics, discusses interpretative approaches to test results and shares his working template for hydrogen sulfide gas interpretation.
Watch this webinar to learn about SIBO testing, clinical impressions, and unique breath test results. Special guest Gary Stapleton, CEO of Aerodiagnostics, discusses interpretative approaches to test results and shares his working template for hydrogen sulfide gas interpretation.
About the Speaker
Gary Stapleton served in the United States Marine Corps before launching his career in commercial health care with an MBA from Long Island University. He began with Astra USA, later AstraZeneca, where he was integral in the successful launches of blockbuster pharmaceuticals including Prilosec, Nexium, and Crestor. He then joined Bausch & Lomb as Vice President of Sales and Marketing, launched the first Caris Life Sciences molecular diagnostic, served as CEO at Lerner Medical Devices, and attracted new and innovative diagnostic tests as COO for the Calloway Laboratories national toxicology laboratory. The founder of Aerodiagnostics LLC, Gary now helps provide the highest level of diagnostic accuracy and customer service for patients and clinicians..